Home › Compare › VPTDF vs EQR

VPTDF vs EQR: Dividend Comparison 2026

VPTDF yields 2312.14% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VPTDF wins by $38613850936.57M in total portfolio value
10 years
VPTDF
VPTDF
● Live price
2312.14%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38613850936.61M
Annual income
$35,586,201,922,515,856.00
Full VPTDF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — VPTDF vs EQR

📍 VPTDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVPTDFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VPTDF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VPTDF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VPTDF
Annual income on $10K today (after 15% tax)
$196,531.79/yr
After 10yr DRIP, annual income (after tax)
$30,248,271,634,138,476.00/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, VPTDF beats the other by $30,248,271,634,135,228.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VPTDF + EQR for your $10,000?

VPTDF: 50%EQR: 50%
100% EQR50/50100% VPTDF
Portfolio after 10yr
$19306925468.33M
Annual income
$17,793,100,961,259,838.00/yr
Blended yield
92.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

VPTDF
No analyst data
Altman Z
-272.5
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VPTDF buys
0
EQR buys
0
No recent congressional trades found for VPTDF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVPTDFEQR
Forward yield2312.14% ✓4.73%
Annual dividend / share$2.00$2.77 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$38613850936.61M ✓$40.5K
Annual income after 10y$35,586,201,922,515,856.00 ✓$3,819.61
Total dividends collected$38401207511.77M ✓$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VPTDF vs EQR ($10,000, DRIP)

YearVPTDF PortfolioVPTDF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$241,914$231,213.87$11,248$547.57+$230.7K → VPTDF
2$5,486,310$5,227,462.00$12,701$666.53+$5.47M → VPTDF
3$116,667,010$110,796,658.85$14,405$814.59+$116.65M → VPTDF
4$2,326,799,779$2,201,966,078.24$16,413$999.84+$2326.78M → VPTDF
5$43,532,552,320$41,042,876,556.38$18,795$1,232.92+$43532.53M → VPTDF
6$764,223,950,336$717,644,119,353.02$21,639$1,527.95+$764223.93M → VPTDF
7$12,591,932,032,884$11,774,212,406,024.32$25,057$1,903.80+$12591932.01M → VPTDF
8$194,782,556,253,371$181,309,188,978,186.10$29,197$2,385.87+$194782556.22M → VPTDF
9$2,829,578,517,848,077$2,621,161,182,656,969.50$34,250$3,008.70+$2829578517.81M → VPTDF
10$38,613,850,936,613,300$35,586,201,922,515,856.00$40,467$3,819.61+$38613850936.57M → VPTDF

VPTDF vs EQR: Complete Analysis 2026

VPTDF — Stock

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

Full VPTDF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this VPTDF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VPTDF vs SCHDVPTDF vs JEPIVPTDF vs OVPTDF vs KOVPTDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.